cystic
fibrosi
cf
progress
ill
affect
mani
system
includ
respiratori
gastrointestin
urogenit
sweat
gland
cf
inherit
autosom
recess
diseas
caus
mutat
cf
transmembran
conduct
regul
cftr
gene
one
live
birth
caucasian
popul
affect
cf
make
common
autosom
recess
diseas
delet
phenylalanin
amino
acid
posit
chromosom
consid
common
mutat
north
america
western
europ
past
year
life
expect
cf
patient
improv
significantli
respiratori
virus
report
caus
respiratori
damag
patient
cystic
fibrosi
wat
et
al
suggest
respiratori
virus
associ
pulmonari
exacerb
cf
patient
led
diseas
progress
pulmonari
function
test
pft
abnorm
armstrong
et
al
show
cf
infant
admit
hospit
respiratori
symptom
viral
infect
thirtyf
percent
acquir
pseudomona
aeruginosa
pa
compar
hospit
author
also
show
associ
respiratori
viral
infect
inflammatori
chang
airway
respiratori
viral
infect
caus
respiratori
epitheli
injuri
lead
increas
adher
bacteri
pathogen
pharyng
cell
bacteria
includ
staphylococcu
aureu
aureu
hemophilu
influenza
h
influenza
streptococcu
pneumonia
pneumonia
pseudomona
aeruginosa
pa
report
common
agent
caus
viral
infect
patient
cf
age
year
respiratori
syncyti
viru
influenza
parainfluenza
adenoviru
commonli
detect
patient
age
year
hiatt
p
w
et
al
suggest
cf
infant
respiratori
viral
infect
signific
risk
lower
respiratori
tract
infect
hospit
longterm
deterior
lung
function
bellinghausen
et
al
suggest
preexposur
normal
respiratori
bacteria
may
modifi
respons
lung
epithelia
virus
may
explain
suscept
pulmonari
exacerb
banjar
et
al
found
pa
detect
cf
patient
h
influenza
detect
cf
patient
aureu
pneumonia
methicillinresist
staphylococcu
aureu
mrsa
cf
patient
author
also
found
develop
earli
pa
resist
antibiot
shown
contribut
earli
mortal
cf
patient
carri
studi
determin
preval
virus
cystic
fibrosi
patient
find
correl
bacteri
cultur
cftr
mutat
pulmonari
function
test
pft
tertiari
care
center
saudi
arabia
consid
main
referr
center
cf
patient
obtain
preval
viral
infect
cf
patient
identifi
relat
bacteri
infect
cftr
mutat
pulmonari
function
test
pft
obtain
ethic
approv
retrospect
review
chart
patient
cystic
fibrosi
age
group
screen
detect
virus
respiratori
exacerb
januari
june
polymeras
chain
reaction
pcr
respiratori
virus
extract
analyz
accord
standard
method
patient
cf
diseas
diagnos
phenotyp
cf
characterist
includ
chronic
sinopulmonari
diseas
characterist
gastrointestin
pancreat
abnorm
absenc
va
deferen
sweat
chlorid
concentr
mmoll
loss
cftrmediat
tran
epitheli
conduct
nasal
epithelium
defin
recent
chang
least
two
follow
condit
increas
dyspnea
chang
sputum
volum
color
increas
cough
increas
malais
fatigu
lethargi
anorexia
weight
loss
decreas
pulmonari
function
radiograph
chang
viral
recurr
defin
viral
reinfect
similar
differ
viru
neg
pcr
within
period
month
cf
patient
age
underw
pcr
multiplex
respiratori
virus
follow
period
januari
june
includ
induc
sputum
sampl
obtain
patient
year
age
nasopharyng
aspir
npa
taken
patient
unabl
expector
age
year
broncho
alveolar
lavag
bal
sampl
taken
sever
ill
patient
pulmonari
diseas
admit
hospit
multiplex
pcr
test
detect
respiratori
virus
bacteri
cultur
collect
process
accord
standard
methodolog
sampl
collect
follow
standard
hospit
precaut
ttest
use
calcul
continu
variabl
median
mean
standard
deviat
valu
express
mean
standard
deviat
sd
result
present
level
signific
p
method
use
assess
lung
capac
pft
done
accord
standard
procedur
consid
mild
moder
moder
sever
sever
less
sever
examin
npasputum
bal
sampl
cystic
fibrosi
patient
respiratori
exacerb
tertiari
care
center
sampl
collect
year
includ
analysi
total
patient
pulmonari
exacerb
viral
pcr
perform
fiftyeight
patient
posit
viral
pcr
patient
patient
male
patient
femal
fortyf
patient
aliv
patient
die
twentyf
patient
refer
eastern
region
central
region
north
south
western
region
method
sampl
collect
mostli
nasopharyng
aspir
npa
bronchoalveolar
lavag
bal
induc
sputum
seventyfour
posit
first
viral
pcr
obtain
total
pcr
sampl
patient
one
type
virus
frequent
report
viru
rhinoviru
sampl
adenoviru
human
parainfluenza
viru
hpiv
bocaviru
enteroviru
coronaviru
human
respiratori
syncyti
viru
rsv
middl
east
respiratori
syndrom
coronaviru
merscov
influenza
viru
influenza
b
viru
viral
pcr
colder
season
octoberefebruari
warmer
season
marcheseptemb
fig
show
frequenc
viral
infect
higher
colder
season
rhinoviru
infect
two
peak
winter
summer
season
rhinoviru
case
patient
infect
decemb
patient
june
respect
fig
viral
infect
collect
respiratori
sampl
patient
bacteri
cultur
result
posit
result
patient
infect
one
type
bacteria
thirteen
infect
pa
aureu
pneumonia
escherichia
coli
e
coli
h
influenza
pseudomona
cepacian
bacteri
organ
tabl
follow
month
period
post
viral
infect
bacteri
sampl
obtain
result
posit
cultur
infect
aureu
mucoid
p
aeruginosa
h
influenza
e
coli
pneumonia
klebsiella
organ
patient
infect
gramneg
bacteria
tabl
thirteen
patient
recurr
viral
infect
within
month
posit
viral
pcr
patient
rhinoviru
infect
adenoviru
found
bocaviru
coronaviru
enteroviru
viral
recurr
bacteri
sampl
taken
cultur
result
posit
bacteri
cultur
two
six
infect
staphylococcu
h
influenza
p
aeruginosa
streptococcu
cftr
analysi
perform
patient
total
mutat
found
common
mutat
lead
viral
infect
intron
patient
exon
patient
intron
patient
exon
patient
eastern
provinc
highest
viral
infect
tabl
twenti
patient
underw
pft
analysi
detect
determin
diseas
sever
eighteen
second
pft
analysi
includ
studi
four
eighteen
normal
pft
obstruct
restrict
combin
obstruct
restrict
pattern
tabl
sever
pft
show
normal
pft
mild
moder
sever
moder
sever
tabl
follow
pft
post
viral
infect
show
signific
differ
type
sever
pft
patient
patient
aliv
die
three
patient
die
mucoid
p
aeruginosa
staphylococcu
aureu
streptococcu
e
coli
patient
organ
potenti
signific
respiratori
virus
cf
patient
report
studi
wark
et
al
show
viral
respiratori
tract
infect
associ
exacerb
cf
case
associ
increas
respiratori
symptom
burn
et
al
show
major
virus
identifi
throughout
studi
rhinovirus
esposito
et
al
show
human
rhinoviru
commonli
associ
viral
infect
cf
patient
rhinoviru
detect
significantli
associ
occurr
cf
pulmonari
exacerb
ramirez
ia
et
al
made
comparison
pulmonari
exacerb
associ
rhinoviru
influenza
viru
virusneg
specimen
show
virus
associ
immun
respons
tailor
specif
infect
studi
show
rhinoviru
preval
viru
fortun
preval
influenza
viru
popul
minimum
possibl
due
annual
routin
influenza
vaccin
armstrong
et
al
report
respiratori
virus
play
major
role
cf
hospit
associ
acquisit
p
aeruginosa
although
viral
infect
selflimit
respiratori
viru
infect
togeth
bacteri
infect
may
enhanc
inflamm
may
lead
chronic
bacteri
infect
bacteri
speci
p
aeruginosa
studi
report
respiratori
virus
patient
cf
acut
pulmonari
exacerb
patient
also
note
viral
infect
increas
preval
bacteri
infect
specif
pathogen
h
influenza
aureu
tabl
also
found
frequent
report
viru
rhinoviru
sampl
p
valu
studi
show
viral
recurr
occur
within
month
patient
mainli
rhinovir
infect
also
note
h
influenza
aureu
commonli
report
bacteri
pathogen
viral
recurr
wang
et
al
report
viral
infect
associ
bacteri
respiratori
exacerb
hospit
admiss
addit
declin
pft
also
report
associ
progress
pulmonari
diseas
number
annual
viral
infect
exact
mechan
microbi
synerg
known
studi
followup
pft
post
viral
infect
show
signific
differ
type
sever
pft
compar
initi
pft
viral
ill
tabl
could
relat
small
sampl
size
abl
pft
techniqu
emerson
et
al
show
patient
infect
p
aeruginosa
time
increas
risk
death
similarli
studi
patient
die
infect
mucoid
p
aeruginosa
may
support
assumpt
p
aeruginosa
may
increas
risk
death
patient
cf
popul
patient
die
whole
cystic
fibrosi
popul
patient
viral
infect
studi
done
describ
associ
specif
genet
mutat
viral
infect
viral
infect
contribut
increas
morbid
mortal
cf
patient
popul
rhinoviru
common
caus
agent
viral
infect
viral
recurr
increas
preval
bacteri
infect
specif
pathogen
h
influenza
aureu
physician
awar
prevent
progress
lung
damag
cf
patient
treat
concomit
viral
bacteri
infect
viral
infect
may
associ
common
cftr
mutat
